Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-11.51%
+2.23%
-1.97%
+21.68%
Most Trending
-11.51%
+2.23%
-1.97%
+21.68%
11 Feb 2026$U Unity software shares collapsed more than 26% despite a Q4 earnings and revenue beat, as weak forward guidance triggered heavy selling and pushed the stock back into oversold territory on massive volume.
$LYFT Lyft shares dropped nearly 17% after missing on revenue and reporting softer rider metrics, overshadowing partnership growth and raising doubts about the path to long-term profitability targets.
$HOOD Robinhood markets fell close to 9% even after an earnings beat, as revenue disappointed on crypto weakness and quarterly income declined year over year, cooling enthusiasm around its growth narrative.
$SHOP Shopify slid over 6% following earnings miss, with margin pressure and softer free-cash-flow guidance outweighing a revenue beat and a newly announced $2 billion buyback plan.
$MU Micron technology surged nearly 10% as AI-driven memory demand and improving pricing trends boosted confidence, making it one of the strongest performers in the Nasdaq 100.
$KHC Kraft Heinz traded roughly flat after mixed results, beating on earnings but showing declining organic sales while pausing its breakup plan to focus on operational improvements.
$CSCO Cisco systems edged lower despite topping earnings and revenue estimates, as weaker gross margins and cautious positioning limited upside momentum.
$PANW Palo alto networks dipped slightly ahead of earnings, with analysts adjusting targets while investors await clearer signals on billings growth and forward guidance.
$NET Cloudflare rallied more than 5% after delivering strong Q4 revenue growth and solid guidance, reinforcing confidence in its expansion within high-growth cybersecurity markets.
$MRNA Moderna declined after the FDA refused to review its seasonal flu vaccine filing, adding regulatory uncertainty and pressuring shares in a volatile biotech environment.
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 5,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
FIND US ON
Join over 5,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Night.Owl
Pro Members
